Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
Want to see HK:6833 full AI Analyst Report?
Total Valuation
Sinco Pharmaceuticals Holdings Ltd. has a market cap or net worth of HK$341.53M. The enterprise value is HK$103.33M.
Market CapHK$341.53M
Enterprise ValueHK$103.33M
Share Statistics
Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,032,890,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinco Pharmaceuticals Holdings Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.92%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)5.92%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee7.16M
Profits Per Employee116.67K
Employee Count291
Asset Turnover1.13
Inventory Turnover7.17
Valuation Ratios
The current PE Ratio of Sinco Pharmaceuticals Holdings Ltd. is 8.6. Sinco Pharmaceuticals Holdings Ltd.’s PEG ratio is -0.53.
PE Ratio8.6
PS Ratio0.16
PB Ratio0.47
Price to Fair Value0.47
Price to FCF2.04
Price to Operating Cash Flow1.68
PEG Ratio-0.53
Income Statement
In the last 12 months, Sinco Pharmaceuticals Holdings Ltd. had revenue of 2.08B and earned 34.85M in profits. Earnings per share was 0.02.
Revenue2.08B
Gross Profit222.09M
Operating Income72.00M
Pretax Income48.26M
Net Income34.85M
EBITDA93.45M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 181.03M and capital expenditures -10.10M, giving a free cash flow of 170.93M billion.
Operating Cash Flow181.03M
Free Cash Flow170.93M
Free Cash Flow per Share0.08
Dividends & Yields
Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HK$0.002, resulting in a dividend yield of 1.12%
Dividend Per ShareHK$0.002
Dividend Yield1.12%
Payout Ratio8.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change-6.15%
50-Day Moving Average0.18
200-Day Moving Average0.19
Relative Strength Index (RSI)40.26
Average Volume (3m)210.00K
Important Dates
Sinco Pharmaceuticals Holdings Ltd. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Sinco Pharmaceuticals Holdings Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 26.42%
Current Ratio1.18
Quick Ratio0.95
Debt to Market Cap0.56
Net Debt to EBITDA-2.04
Interest Coverage Ratio2.18
Taxes
In the past 12 months, Sinco Pharmaceuticals Holdings Ltd. has paid 13.41M in taxes.
Income Tax13.41M
Effective Tax Rate0.28
Enterprise Valuation
Sinco Pharmaceuticals Holdings Ltd. EV to EBITDA ratio is 1.44, with an EV/FCF ratio of 0.84.
EV to Sales0.06
EV to EBITDA1.44
EV to Free Cash Flow0.84
EV to Operating Cash Flow0.80
Balance Sheet
Sinco Pharmaceuticals Holdings Ltd. has HK$374.53M in cash and marketable securities with HK$183.47M in debt, giving a net cash position of HK$191.07M billion.
Cash & Marketable SecuritiesHK$374.53M
Total DebtHK$183.47M
Net CashHK$191.07M
Net Cash Per ShareHK$0.09
Tangible Book Value Per ShareHK$0.28
Margins
Gross margin is 10.65%, with operating margin of 3.45%, and net profit margin of 1.67%.
Gross Margin10.65%
Operating Margin3.45%
Pretax Margin2.32%
Net Profit Margin1.67%
EBITDA Margin4.48%
EBIT Margin3.58%
Analyst Forecast
The average price target for Sinco Pharmaceuticals Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-26.20%
EPS Growth Forecast-17.41%